All companies › KMTS

KMTS · KESTRA MEDICAL TECHNOLOGIES, LTD.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells13
Research cases0
Last filing2026-10-29

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-08 — Schwartz Jeffrey Lawrence · sold 3,890 @ $25.18 2026-09-08 — Ladone Mary Kay · sold 3,908 @ $25.20 2026-09-08 — Reilly Kevin C · sold 2,932 @ $25.13 2026-09-08 — Hanley Conor · sold 5,694 @ $25.25 2026-09-21 — Kwo Elizabeth · sold 4,010 @ $24.26 2026-09-30 — COHEN RAYMOND W · sold 3,330 @ $29.28 2026-10-20 — Webster Brian Daniel · sold 13,316 @ $29.52 2026-10-20 — Webster Brian Daniel · sold 1,684 @ $29.89 2026-10-21 — Umberger Traci S · sold 96,404 @ $27.15 2026-10-21 — Umberger Traci S · sold 3,596 @ $28.09 2026-10-27 — Mahboob Vaseem · sold 34,809 @ $30.04 2026-10-28 — Mahboob Vaseem · sold 39,903 @ $30.48 2026-10-29 — Mahboob Vaseem · sold 4,788 @ $30.60
2026-09-082026-10-29

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Mahboob Vaseem Chief Financial Officer
Webster Brian Daniel See Remarks, Director
Umberger Traci S See Remarks, Director
Schwartz Jeffrey Lawrence Director, 10% owner
Ladone Mary Kay Director
Reilly Kevin C Director
Hanley Conor Director
Kwo Elizabeth Director
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $KMTS is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-10-29', 'insider_name': 'Mahboob Vaseem', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 4788.0, 'price': 30.5979, 'value': 146502.75, 'is_buy': False}, {'transaction_date': '2026-10-28', 'insider_name': 'Mahboob Vaseem', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 39903.0, 'price': 30.4815, 'value': 1216303.29, 'is_buy': False}, {'transaction_date': '2026-10-27', 'insider_name': 'Mahboob Vaseem', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 34809.0, 'price': 30.0435, 'value': 1045784.19, 'is_buy': False}, {'transaction_date': '2026-10-21', 'insider_name': 'Umberger Traci S', 'insider_title': 'See Remarks, Director', 'transaction_type': 'Open-market sell', 'shares': 96404.0, 'price': 27.1493, 'value': 2617301.12, 'is_buy': False}, {'transaction_date': '2026-10-21', 'insider_name': 'Umberger Traci S', 'insider_title': 'See Remarks, Director', 'transaction_type': 'Open-market sell', 'shares': 3596.0, 'price': 28.0915, 'value': 101017.03, 'is_buy': False}, {'transaction_date': '2026-10-20', 'insider_name': 'Webster Brian Daniel', 'insider_title': 'See Remarks, Director', 'transaction_type': 'Open-market sell', 'shares': 13316.0, 'price': 29.5172, 'value': 393051.04, 'is_buy': False}, {'transaction_date': '2026-10-20', 'insider_name': 'Webster Brian Daniel', 'insider_title': 'See Remarks, Director', 'transaction_type': 'Open-market sell', 'shares': 1684.0, 'price': 29.892, 'value': 50338.13, 'is_buy': False}, {'transaction_date': '2026-09-30', 'insider_name': 'COHEN RAYMOND W', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 3330.0, 'price': 29.2805, 'value': 97504.07, 'is_buy': False}, {'transaction_date': '2026-09-21', 'insider_name': 'Kwo Elizabeth', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 4010.0, 'price': 24.26, 'value': 97282.6, 'is_buy': False}, {'transaction_date': '2026-09-08', 'insider_name': 'Schwartz Jeffrey Lawrence', 'insider_title': 'Director, 10% owner', 'transaction_type': 'Open-market sell', 'shares': 3890.0, 'price': 25.178, 'value': 97942.42, 'is_buy': False}, {'transaction_date': '2026-09-08', 'insider_name': 'Ladone Mary Kay', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 3908.0, 'price': 25.2, 'value': 98481.6, 'is_buy': False}, {'transaction_date': '2026-09-08', 'insider_name': 'Reilly Kevin C', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 2932.0, 'price': 25.13, 'value': 73681.16, 'is_buy': False}, {'transaction_date': '2026-09-08', 'insider_name': 'Hanley Conor', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 5694.0, 'price': 25.25, 'value': 143773.5, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for KMTS today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.